Evidence map›Paper›PMID 31249318›Full record

ArticleScientific reports2019

Tremorgenic effects and functional metabolomics analysis of lolitrem B and its biosynthetic intermediates.

Priyanka Reddy, Simone Rochfort, Elizabeth Read, Myrna Deseo, Emily Jaehne, Maarten Van Den Buuse, Kathryn Guthridge, Martin Combs, German Spangenberg, Jane Quinn

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Priyanka ReddyAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
Simone RochfortAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia. simone.rochfort@ecodev.vic.gov.au.ORCID http://orcid.org/0000-0001-8442-6081
Elizabeth ReadAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
Myrna DeseoAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.ORCID http://orcid.org/0000-0001-6260-4748
Emily JaehneSchool of Psychology and Public Health, La Trobe University, Bundoora, Victoria, 3083, Australia.
Maarten Van Den BuuseSchool of Psychology and Public Health, La Trobe University, Bundoora, Victoria, 3083, Australia.
Kathryn GuthridgeAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
Martin CombsSchool of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia.ORCID http://orcid.org/0000-0003-0606-7284
German SpangenbergAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
Jane QuinnSchool of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia.ORCID http://orcid.org/0000-0002-9310-0291
La Trobe University · AUAgriculture Victoria · AUCharles Sturt University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neuroactive mycotoxin lolitrem B causes a neurological syndrome in grazing livestock resulting in hyperexcitability, muscle tremors, ataxia and, in severe cases, clonic seizures and death. To define the effects of the major toxin lolitrem B in the brain, a functional metabolomic study was undertaken in which motor coordination and tremor were quantified and metabolomic profiling undertaken to determine relative abundance of both toxin and key neurotransmitters in various brain regions in male mice. Marked differences were observed in the duration of tremor and coordination between lolitrem B pathway members, with some showing protracted effects and others none at all. Lolitrem B was identified in liver, kidney, cerebral cortex and thalamus but not in brainstem or cerebellum which were hypothesised previously to be the primary site of action. Metabolomic profiling showed significant variation in specific neurotransmitter and amino acid profiles over time. This study demonstrates accumulation of lolitrem B in the brain, with non-detectable levels of toxin in the brainstem and cerebellum, inducing alterations in metabolites such as tyrosine, suggesting a dynamic catecholaminergic response over time. Temporal characterisation of key pathways in the pathophysiological response of lolitrem B in the brain were also identified.

Indexed as

Biosynthetic PathwaysMetabolomicsAnimalsBrainDisease Models, AnimalDose-Response Relationship, DrugIndole AlkaloidsMiceMycotoxinsOrgan SpecificityROC CurveTremorIndole Alkaloidslolitrem BMycotoxins

Identifiers

PMID31249318
PMCPMC6597573
OpenAlexW2954244067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.